Viewing Study NCT02601703


Ignite Creation Date: 2025-12-24 @ 7:22 PM
Ignite Modification Date: 2026-02-24 @ 5:04 PM
Study NCT ID: NCT02601703
Status: COMPLETED
Last Update Posted: 2019-07-31
First Post: 2015-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
Sponsor: Glenmark Pharmaceuticals Ltd. India
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atopic Dermatitis View
Keywords: